A Study of the Efficacy of ABT-199 in Subjects With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia With the 17p Deletion
This study is ongoing, but not recruiting participants.
First Posted: June 28, 2013
Last Update Posted: August 28, 2017
Information provided by (Responsible Party):